Pemetrexed is a folate analogue that inhibits several folate-dependent enzymes in addition to thymidylate synthase, and was therefore thought to have theoretical advantages over fluoropyrimidines in the treatment of colorectal cancer [38]. Here, TYMS is linked to colorectal cancer.